Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: Results from a randomised trial of exemestane vs megestrol acetateMARTINETTI, Antonia; ZILEMBO, Nicoletta; SEREGNI, Ettore et al.Anticancer research. 2003, Vol 23, Num 4, pp 3485-3491, issn 0250-7005, 7 p.Article

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung CancerSHAW, Alice T; KIM, Dong-Wan; WU, Yi-Long et al.The New England journal of medicine. 2013, Vol 368, Num 25, pp 2385-2394, issn 0028-4793, 10 p.Article

Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancerLØNNING, Per E; GEISLER, Jürgen; POLLI, Anna et al.Journal of clinical oncology. 2005, Vol 23, Num 22, pp 5126-5137, issn 0732-183X, 12 p.Conference Paper